Navigation Links
VerifyNow System

ProductsVerifyNow System
Company Accumetrics
Item VerifyNow System
Features Each single-use disposable assay device, such as the VerifyNow IIb/IIIa or VerifyNow Aspirin Assay, contains all needed reagents to provide analytical results for a specific assay. Assay devices are individually pouched and may be used until the expiration date printed on each kit box and foil pouch.

The assay device consists of the following components:

  • Finger Grip: Each assay device has a handle with which the user can insert or remove the assay device from the assay device port.
  • Staging Well: The blood sample is held in this area for temperature stabilization prior to analysis.
  • Assay Device Spot Code: Each assay device is labeled with a unique spot code. Upon insertion of the assay device into the assay device port, the instrument automatically scans the spot code and determines which assay is being performed, records the lot number, and verifies that the assay device has not expired.
  • Sample Well: The sample well is the area of the assay device where the blood collection tube is inserted. The well contains a Blood Collection Tube Spike for sampling directly from a closed blood collection tube. A protective sheath is removed from the assay device spike before use.
  • Humidity Indicator: Each assay device has a humidity sensor to determine whether the assay device has been exposed to excess humidity.
  • Mixing Chamber/Detection Wells: The wells contain all necessary reagents for the specific assays.
Description The Company's first commercial product is the VerifyNow System, a point-of-care, bedside instrument with single-use, disposable assay devices . The advantages of the VerifyNow System over previous products are direct use of a vacuum-type blood collection tube (whole blood sample) and a result in minutes. VerifyNow IIb/IIIa, the first assay developed for use on the system is to assess GP IIb/IIIa platelet inhibition in response to abciximab or eptifibatide. VerifyNow Aspirin, the second assay developed for use on the system is to aid in the detection of platelet dysfunction due to aspirin ingestion.

The GP IIb/IIIa inhibitor class of intravenous antiplatelet agents, has demonstrated benefit in treating patients undergoing coronary interventions (e.g. PTCA and stent placement) and acute coronary syndromes. Currently available drugs in this class include ReoPro (Centocor), Integrilin (Millenium Pharmaceuticals) and Aggrastat(Merck & Co.). Accumetrics estimates that over 2.5 million patients annually are candidates for intravenous antiplatelet therapy. Data from clinical trials suggest that both the safety and efficacy of these agents are dependent on achieving a specific level of receptor blockade. Since there are individual variations in the response to these agents, Accumetrics' first product is targeted to address this unmet medical need.

Aspirin, the most commonly used antithrombotic medication in the world, prevents heart attack, stroke, and other vascular events by causing platelet dysfunction, so that platelets will not aggregate. Over 20 million people in the U.S. alone take aspirin daily to prevent platelets from clotting. Clinical data shows that not all patients receive the full benefits of aspirin, therefore it is important to ensure that patients are receiving the expected anti-platelet benefits. Accumetrics second product is designed to address this important medical need.

Info Accumetrics
Customer Service: (800) 643-1640

Related medicine products :

1. VerifyNow Aspirin Assay
2. VerifyNow IIb/IIIa Assay
3. VerifyNow Clopidogrel Assay
4. VerifyNow (Ultegra) System
5. Silicone Oil Cannula System - 20 Gauge
6. Silicone Oil Cannula System - 19 Gauge
7. SuperVu Galilean System
8. KOWA nonmyd 7 / VK-2 Digital Imaging System
9. KOWA nonmyd a-D / VK-2 Digital Imaging System
10. Refraction System RT-2100
11. Odyssey Phacoemulsification System
... provides a simple, fast and cost-effective method ... samples. This system utilizes guanidine thiocyanate and ... and denature proteins. Purified viral RNA is ... and RNase protection assays. This system is ...
The PersonalLAB junior is an automated microplate analyzer capable of fully automating immunoenzymatic techniques using a microplate format, per the reagent manufacturer's instruction for use and spe...
... computer-enhanced microplate reader with a ... flexible and rapid photometric analysis. ... and reliable photometric measurement of ... shaking before reading) and can ...
... can combine a number of assay ... on a simple to use benchtop ... a multifunctional stand-alone device but also ... systems. Custom and standard add-on modules ...
Medicine Products:
(Date:3/28/2017)... Angeles, CA (PRWEB) , ... March 28, 2017 ... ... credential, which will be offered by the American Association of Integrative Medicine and ... presentations for healthcare providers at the AutismOne 2017 Conference in Colorado Springs. , ...
(Date:3/28/2017)... ... March 28, 2017 , ... With expansion and efficiency in mind, Patten Seed ... The seed processing plant opened in Marshallville in 2006, and a bagging and shipping ... opportunity for transition of Patten Seed operations to the Middle Georgia location from their ...
(Date:3/28/2017)... MO (PRWEB) , ... March 28, 2017 , ... ... of job satisfaction in their profession as their value increases in the healthcare ... that provides resources such as job boards, career fairs, and candidate leads to ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... for clear braces. People who want straight teeth without the extensive time commitment ... in Clearwater, FL, without acquiring a referral. A custom-designed series of virtually invisible ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... ability to gain site attention and engagement over the household brands of Top-20 ... webinar will discuss how partnering with the right outsourcing payments provider can ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 2017  BERG, a biopharmaceutical company uncovering ... approach, today announced that the company,s Interrogative ... new data using a cold-induced model to ... Joslin Diabetes Center led the investigation with ... analysis of samples.  The findings were published ...
(Date:3/27/2017)... and BOSTON , ... a leading global pharmaceutical company and Paratek Pharmaceuticals, ... the development and commercialization of innovative therapies based ... 3 trials of sarecycline for the treatment of ... primary efficacy endpoints. Sarecycline is a once-daily, oral, ...
(Date:3/27/2017)...  PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical company ... in children, today reported financial results for the ... 2016 and provided an update on its corporate ... progress during the fourth quarter of 2016 through ... safety study, and with our lead development candidate, ...
Breaking Medicine Technology: